Remove Data Remove Law Remove Media Remove Pets
article thumbnail

FDA Publish Article “5 Things to Know about Delta-8 Tetrahydrocannabinol – Delta-8 THC”

Cannabis Law Report

They may be marketed in ways that put the public health at risk and should especially be kept out of reach of children and pets. Selling unapproved products with unsubstantiated therapeutic claims is not only a violation of federal law, but also can put consumers at risk, as these products have not been proven to be safe or effective.

THC 105
article thumbnail

cbdMD Therapeutics Announces Launch Of Animal Health Study In Collaboration With Colorado State University’s Veterinary Program

Cannabis Law Report

Study To Explore Effects of cbdMD’s Proprietary Cannabinoid Blend On Pets Who Suffer From Osteoarthritis. The results from this study will provide validating data on the efficacy of the Company’s products in reducing pain and improving joint mobility in dogs. CHARLOTTE, N.C.–(BUSINESS and are difficult to predict.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

cbdMD Therapeutics Releases Research Plan

Cannabis Law Report

The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. This safety data will support the ensuing preclinical trials in humans to explore the efficacy of the cannabinoids. does not undertake any duty to update any forward-looking statements except as may be required by law.

article thumbnail

CBD is Everywhere – But Where Does the FDA Stand?

The Blunt Truth

Current federal law expressly allows for the distribution of hemp-derived CBD products that contain 0.3% Other CBD products, however, are still subject to various state law regulations as well as the U.S. The FDA is collecting data to fill these gaps. tetrahydrocannabidiol (THC) or less to be sold, with certain caveats.

CBD 80
article thumbnail

Curaleaf shares down 8% after FDA sends warning letter over CBD health claims

Cannabis Law Report

Curaleaf CURLF, -7.27% is “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases,” the FDA wrote. Full report at. Full Letter. Source: [link].

CBD 51
article thumbnail

cbdMD Announces Exclusive Multi-Year Partnership With Amazon Platform Partner Amify

Cannabis Law Report

As the first Amazon-as-a-Service provider, we serve as an outsourced Amazon team, which helps companies own their brand on the world’s largest ecommerce platform by leveraging cross channel data to increase sales and improve customer experience. and are difficult to predict. cbdMD, Inc.

article thumbnail

Coming Soon Our Newest Columnist, Shane Eloe, Senior Accountant, Dickinson & Clark CPAs, PC Council Bluffs, Iowa

Cannabis Law Report

I think some of those people would be more comfortable with cloud computing if they visited a reputable data center and saw what the security looked like there. Most of the information I am interested in seeing is freely available online, and I really don’t care that old media still measures itself with circulation statistics.

Access 40